About this event
The NHS needs to shift patient care increasingly out of hospital to make care more affordable, accessible and timely. For pharma and medtech partners, enabling new patient pathways to alleviate the pressures on secondary care and accelerate patient access is of paramount importance.
This webinar explores how industry and NHS partners can establish remote and community-based services that maintain clinical standards while removing logistical barriers for patients. We will share insights from two CHASE-managed projects that successfully transitioned specialist care from local hospitals into primary care settings. These initiatives provide a practical framework for how industry can support service redesign to meet current system needs.
This 45-minute session will cover:
Hosted by
Cat specialises in analysis of NHS priorities, and the pain points faced by NHS commissioners. Having worked extensively on patient-empowering programmes, Cat is passionate about finding win-win solutions that benefit patients, the NHS and its partners. She will host today's discussion.
Claire is a Clinical Project Manager with extensive experience in leading complex specialist service redesigns. She focuses on the operational deployment of nurse-led clinics in secondary and community settings.
Shaun focuses on advancing pharmacist-led clinical services. He has spearheaded the development of strategic training programs that empower pharmacists to manage specialist monitoring in a variety of healthcare settings.
With over 25 years in healthcare, Jyotika specialises in NHS insights and market access strategies. Her role focuses on fostering collaboration between industry and the NHS to develop value-driven solutions.
As a former Senior Immunisation Manager at NHS England, she led teams of commissioners to deliver the national childhood and adult immunisation programmes, giving her an invaluable understanding of the system's operational challenges and strategic goals. This, combined with her recent experience as Commercial Director at Pfizer for the COVID-19 treatment, allows her to provide expert insight into designing clinically effective and commercially viable services for the NHS.
At CHASE, we specialise in connecting the right people with the right opportunities in the life sciences, healthcare and pharmaceutical industries. With over 25+ years of expertise and a UK-market focus, we’re the trusted partner for organisations seeking people-based solutions.